Development and Evaluation of a Prediction Model for Underestimated Invasive Breast Cancer in Women with Ductal Carcinoma In Situ at Stereotactic Large Core Needle Biopsy

被引:14
|
作者
Diepstraten, Suzanne C. E. [1 ]
van de Ven, Stephanie M. W. Y. [2 ]
Pijnappel, Ruud M. [1 ]
Peeters, Petra H. M. [3 ]
van den Bosch, Maurice A. A. J. [1 ]
Verkooijen, Helena M. [1 ]
Elias, Sjoerd G. [3 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands
[2] Stanford Univ, Med Ctr, Dept Radiol, Stanford, CA 94305 USA
[3] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 10期
关键词
LYMPH-NODE BIOPSY; DIAGNOSIS; DISEASE; RISK; MICROCALCIFICATION; RECOMMENDATIONS; MANAGEMENT; IMPUTATION; SPECIMENS; LESIONS;
D O I
10.1371/journal.pone.0077826
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: We aimed to develop a multivariable model for prediction of underestimated invasiveness in women with ductal carcinoma in situ at stereotactic large core needle biopsy, that can be used to select patients for sentinel node biopsy at primary surgery. Methods: From the literature, we selected potential preoperative predictors of underestimated invasive breast cancer. Data of patients with nonpalpable breast lesions who were diagnosed with ductal carcinoma in situ at stereotactic large core needle biopsy, drawn from the prospective COBRA (Core Biopsy after RAdiological localization) and COBRA2000 cohort studies, were used to fit the multivariable model and assess its overall performance, discrimination, and calibration. Results: 348 women with large core needle biopsy-proven ductal carcinoma in situ were available for analysis. In 100 (28.7%) patients invasive carcinoma was found at subsequent surgery. Nine predictors were included in the model. In the multivariable analysis, the predictors with the strongest association were lesion size (OR 1.12 per cm, 95% CI 0.98-1.28), number of cores retrieved at biopsy (OR per core 0.87, 95% CI 0.75-1.01), presence of lobular cancerization (OR 5.29, 95% CI 1.25-26.77), and microinvasion (OR 3.75, 95% CI 1.42-9.87). The overall performance of the multivariable model was poor with an explained variation of 9% (Nagelkerke's R-2), mediocre discrimination with area under the receiver operating characteristic curve of 0.66 (95% confidence interval 0.58-0.73), and fairly good calibration. Conclusion: The evaluation of our multivariable prediction model in a large, clinically representative study population proves that routine clinical and pathological variables are not suitable to select patients with large core needle biopsy-proven ductal carcinoma in situ for sentinel node biopsy during primary surgery.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
    Si, Jing
    Guo, Rong
    Huang, Naisi
    Xiu, Bingqiu
    Zhang, Qi
    Chi, Weiru
    Wu, Jiong
    CANCER MEDICINE, 2019, 8 (18): : 7586 - 7593
  • [42] Large needle core biopsy - Avoidance of biopsy table bombardment by the biopsy needle in stereotactic guided breast biopsy
    Wong, KW
    Tsui, KW
    Lau, HY
    Yung, WT
    Yeung, MCA
    CLINICAL RADIOLOGY, 1999, 54 (05) : 328 - 330
  • [43] Histologic and radiographic analysis of ductal carcinoma in situ diagnosed using stereotactic incisional core breast biopsy
    Bonnett, M
    Wallis, T
    Rossmann, M
    Pernick, NL
    Carolin, KA
    Segel, M
    Bouwman, D
    Visscher, D
    MODERN PATHOLOGY, 2002, 15 (02) : 95 - 101
  • [44] Does stereotactic core needle biopsy increase the risk of local recurrence of invasive breast cancer?
    Kwo, Sophia
    Grotting, James C.
    BREAST JOURNAL, 2006, 12 (03): : 191 - 193
  • [45] Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: Preoperative predictors of invasive breast cancer
    Park, Ah Young
    Gweon, Hye Mi
    Son, Eun Ju
    Yoo, Miri
    Kim, Jeong-Ah
    Youk, Ji Hyun
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (04) : 654 - 659
  • [46] Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision
    Kim, Jisun
    Han, Wonshik
    Lee, Jong Won
    You, Jee-Man
    Shin, Hee-Chul
    Ahn, Soo Kyung
    Moon, Hyeong-Gon
    Cho, Nariya
    Moon, Woo Kyung
    Park, In-ae
    Noh, Dong-Young
    BREAST, 2012, 21 (05): : 641 - 645
  • [47] Stereotactic Large Core Needle Biopsy for All Nonpalpable Breast Lesions?
    L.E. Hoorntje
    P.H.M. Peeters
    I.H.M. Borel Rinkes
    H.M. Verkooijen
    R.M. Pijnappel
    W.P.Th.M. Mali
    Breast Cancer Research and Treatment, 2002, 73 (2) : 176 - 181
  • [48] Stereotactic large core needle biopsy for all nonpalpable breast lesions?
    Hoorntje, LE
    Peeters, PHM
    Rinkes, IHMB
    Verkooijen, HM
    Pijnappel, RM
    Mali, WPTM
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 73 (02) : 177 - 182
  • [49] Predictors of upstage for invasive breast cancer in women with ductal carcinoma in-situ
    Chan, P.
    Sim, E. J.
    Khin, L. W.
    Tan, E. Y.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 63 - 64
  • [50] Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast
    Prendeville, Susan
    Ryan, Ciara
    Feeley, Linda
    O'Connell, Fionnuala
    Browne, Tara Jane
    O'Sullivan, Martin J.
    Bennett, Michael W.
    BREAST, 2015, 24 (03): : 197 - 200